Women heterozygous for APOE4 have a 4-fold increase in the risk of AD, whereas homozygous women and men with two copies of the APOE4 allele exhibit a 12-15-fold increase in risk as compared to non-carriers [5, 14–16]. The gene discussed is APOE; the disease is Alzheimer disease.